UCLA's Dr. Amar Kishan Wins 2025 Steven A. Leibel Memorial Award for Genitourinary Cancer Research
Dr. Amar Kishan, a prominent figure at UCLA's David Geffen School of Medicine, has been honoured with the 2025 Steven A. Leibel Memorial Award. This prestigious accolade recognises his exceptional contributions to advancing radiation treatments for genitourinary cancers, notably prostate and bladder cancers.
Kishan, also co-director of the cancer molecular imaging program at the Jonsson Comprehensive Cancer Center, has published over 310 peer-reviewed manuscripts in leading journals such as JAMA, The Lancet Oncology, and the Journal of Clinical Oncology. His work is supported by esteemed organisations like the National Institutes of Health and the Prostate Cancer Foundation.
He has led multiple landmark clinical trials, including the MIRAGE study, the LUNAR trial, and the recently launched HEATWAVE trial. Kishan's expertise lies in advanced radiation techniques like stereotactic body radiotherapy (SBRT) and MRI-guided radiation therapy. His dedication to improving cancer patient outcomes has earned him the UCLA Exceptional Physician Award (2024) and the Leonard Tow Humanism in Medicine Award (2021).
Dr. Michael Steinberg, chair of radiation oncology at UCLA, commended Kishan's leadership and commitment. Notably, Kishan received this award within the first decade of his career following board certification, a testament to his remarkable achievements.
Dr. Amar Kishan's groundbreaking research and leadership in radiation treatments for genitourinary cancers have earned him the 2025 Steven A. Leibel Memorial Award. His dedication to improving patient outcomes and mentoring others continues to shape the future of cancer care.
Read also:
- Impact of a Government Shutdown on Citizens
- Medical Specialist Based in Visakhapatnam
- Individuals in New York afflicted by Legionnaires' disease have legitimate legal entitlements. Here's some essential information on the matter.
- Toxic Shock Syndrome: Signs, Origins, Tampon Connection, and Further Details
